Location via proxy:
[ UP ]
[Report a bug]
[Manage cookies]
No cookies
No scripts
No ads
No referrer
Show this form
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
N Engl J Med
.
2021 Apr 22;384(16):1576-1577.
doi: 10.1056/NEJMc2036242.
Epub 2021 Feb 17.
Authors
Danuta M Skowronski
1
,
Gaston De Serres
2
Affiliations
1
British Columbia Centre for Disease Control, Vancouver, BC, Canada danuta.skowronski@bccdc.ca.
2
Institut National de Santé Publique du Québec, Quebec City, QC, Canada.
PMID:
33596348
DOI:
10.1056/NEJMc2036242
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19*
Humans
RNA, Messenger
SARS-CoV-2
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine